Edition:
United Kingdom

West Pharmaceutical Services Inc (WST.N)

WST.N on New York Stock Exchange

119.73USD
18 Sep 2018
Change (% chg)

$0.74 (+0.62%)
Prev Close
$118.99
Open
$118.86
Day's High
$120.24
Day's Low
$118.77
Volume
113,202
Avg. Vol
91,584
52-wk High
$121.11
52-wk Low
$82.79

Summary

Name Age Since Current Position

Patrick Zenner

71 2015 Independent Chairman of the Board

Eric Green

48 2015 President, Chief Executive Officer, Director

Bernard Birkett

49 2018 Chief Financial Officer, Senior Vice President, Treasurer

Annette Favorite

53 2015 Chief Human Resource Officer, Senior Vice President

George Miller

63 2015 Senior Vice President, General Counsel, Corporate Secretary

Silji Abraham

2018 Senior Vice President and Chief Digital and Transformation Officer

Karen Flynn

55 2016 Senior Vice President and Chief Commercial Officer

David Montecalvo

52 2016 Senior Vice President - Global Operations and Supply Chain

Eric Resnick

54 2016 Chief Technology Officer, Vice President

Daniel Malone

56 2011 Vice President, Corporate Controller

Quintin Lai

51 2016 Vice President - Corporate Development, Strategy and Investor Relations

Mark Buthman

57 2011 Independent Director

William Feehery

47 2012 Independent Director

Thomas Hofmann

66 2007 Independent Director

Paula Johnson

58 2005 Independent Director

Deborah Keller Tanner

55 2017 Independent Director

Myla Lai-Goldman

60 2014 Independent Director

Douglas Michels

61 2011 Independent Director

Paolo Pucci

57 2016 Independent Director

John Weiland

62 2007 Independent Director

Biographies

Name Description

Patrick Zenner

Mr. Patrick J. Zenner is Independent Chairman of the Board of the West Pharmaceutical Services, Inc. Mr. Zenner was elected Chairman of the Board effective July 1, 2015. He retired from Hoffmann-La Roche Inc., North America—the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise—in 2001, where he served as President and Chief Executive Officer from 1993 to 2001. He served as Interim Chief Executive Officer of CuraGen Corporation from May 2005 through March 2006. Since then, Mr. Zenner was a director and Chairman of the Board of Exact Sciences Corporation until July 2010, and served as its Interim CEO from July 2007 to March 2008. Currently, Mr. Zenner serves as Chairman of the Board of ArQule, Inc. and a director of Selecta Biosciences, Inc.

Eric Green

Mr. Eric Mark Green is President, Chief Executive Officer, Director of the West Pharmaceutical Services, Inc. Prior to joining the Company, Mr. Green worked at Sigma-Aldrich Corporation, where he served as Executive Vice President and President of the company’s Research Markets business unit since 2013. Mr. Green has a chemistry degree and masters of business administration.

Bernard Birkett

Mr. Bernard John Birkett is Chief Financial Officer, Senior Vice President, Treasurer of the company. He joins the Company from Merit Medical Systems, Inc., a leading manufacturer of disposable medical devices, where he most recently served as Chief Financial Officer and Treasurer. Over a 20-year career at Merit, Mr. Birkett served in a number of senior global leadership roles, including Controller for Europe, Middle East and Africa (EMEA) and Vice President of International Finance. Mr. Birkett began his career as an accountant, and has experience working for additional manufacturing and medical device companies, including Inamed Corporation, Strix Limited and SPS Unbrako International. Mr. Birkett is a Qualified Accountant with a business degree from the National University of Ireland Galway, a master’s degree in banking and finance from Smurfit Business School Dublin, and has completed a program at Stanford’s Graduate School of Business in Strategic Leadership for CFOs.

Annette Favorite

Ms. Annette Favorite is Senior Vice President and Chief Human Resources Officer of West Pharmaceutical Services, Inc. Prior to joining West, she spent more than 25 years at IBM Corporation, an information technology services company, in a number of strategic and global human resources roles. Most recently, she served as Vice President, Global Talent Management.

George Miller

Mr. George Lloyd Miller, J.D., is Senior Vice President, General Counsel, Corporate Secretary of West Pharmaceutical Services, Inc. Previously, he served as Senior Vice President, General Counsel and Corporate Secretary for Sigma-Aldrich Corporation from 2009 to 2015. Prior to working at Sigma-Aldrich, he held senior legal positions with Novartis AG, a global healthcare company.

Silji Abraham

Mr. Silji Abraham is Senior Vice President and Chief Digital and Transformation Officer of the Company. Mr. Abraham brings more than 20 years of experience in leading IT organizations, and most recently served as Executive Vice President and Chief Information Officer (CIO) of MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt,Germany. Prior to this role, Mr. Abraham served as CIO at Sigma-Aldrich Corporation, and worked in various senior IT leadership roles at Invensys Operations Management. He also brings experience working in product engineering, supply chain and software engineering from his time at ArvinMeritor, DaimlerChrysler and Chrysler. Mr. Abraham received a Master's Certificate in Project Management from the George Washington University School of Business and a Master of Business Administration in International Business Operations from Lawrence Technological University. He also holds a Bachelor of Engineering in Computer Engineering from Madurai Kamaraj University.

Karen Flynn

Ms. Karen A. Flynn is Senior Vice President and Chief Commercial Officer of the Company. She was President, Pharmaceutical Packaging Systems from October 2014 to January 2016, President, Pharmaceutical Packaging Systems Americas Region from June 2012 to October 2014, and Vice President, Sales from May 2008 to June 2012. From 2000 to 2008, she worked in Sales Management, most recently as Vice President, Global Accounts, for Catalent (formerly a business segment of Cardinal Health). Prior thereto, she held various positions at West, including Quality, Research and Development, and Sales.

David Montecalvo

Mr. David A. Montecalvo serves as Senior Vice President - Global Operations and Supply Chain of the Company. Prior to joining West, he served in a number of senior leadership roles at Medtronic plc, including Vice President, Contract Manufacturing Operations, for the company's Restorative Therapies Group, and Vice President, Business Operations Integration, where he was responsible for directing and leading the global operations integration of Covidien plc into Medtronic. Prior thereto, he held senior operations and product development roles at Urologix, Inc. and LecTec Corporation.

Eric Resnick

Mr. Eric Resnick is Vice President and Chief Technology Officer of the company. Previously, he served as Vice President and General Manager of Integrated Packaging and Delivery within West's Innovation and Technology Team and President Proprietary Products - Pharmaceutical Delivery Systems from March 2015 until March 2016. He served as Vice President Research and Development and Self-Injection Systems from March 2014 until March 2015, and Vice President and General Manager of West's Contract Manufacturing Delivery Devices division from 2008 until March 2014. Prior thereto, he held various positions of increasing responsibility since joining The Tech Group in 2001. Prior to joining West, he held engineering and operating roles with Eastman Kodak Company and Ortho Clinical Diagnostics.

Daniel Malone

Mr. Daniel Malone is Vice President and Corporate Controller of the Company, since August 2011. He was Vice President of Finance, Pharmaceutical Packaging Systems Americas Region from September 2008 to August 2011 and Director of Financial and Management Reporting from October 1999 to September 2008.

Quintin Lai

Dr. Quintin J. Lai is Vice President, Corporate Development, Strategy and Investor Relations of the company. Prior to joining West, he was Vice President of Investor Relations and Corporate Strategy at Sigma-Aldrich Corporation from 2012 to 2015. From 2002 to 2012, he served as Managing Director and Senior Equity Research Analyst of the Life Science Tools and Diagnostic sector at Robert W. Baird & Company.

Mark Buthman

Mr. Mark A. Buthman is an Independent Director of West Pharmaceutical Services, Inc. Mr. Buthman retired from Kimberly-Clark Corporation in December 2015, where he was Executive Vice President and Chief Financial Officer from January 2003 to April 2015. He held positions of increasing responsibility in finance, strategy and operations after joining Kimberly-Clark in 1982. Mr. Buthman is a Board member of IDEX Corporation, Vice Chairman of the Board of Directors of Pavillon, International and a member of the University of Iowa, Tippie College of Business Advisory Board.

William Feehery

Dr. William F. Feehery, Ph.D., is an Independent Director of West Pharmaceutical Services, Inc. Dr. Feehery has been President of Industrial Biosciences at DowDuPont (previously, E. I. du Pont de Nemours and Company) since November 2013. He served as Global Business Director, DuPont Photovoltaic Solutions and previously as Global Business Director, Electronics Growth Businesses and as President of DuPont Displays, Inc. since joining DuPont in 2002. Before joining DuPont, he was engaged in venture capital and was a management consultant for the Boston Consulting Group.

Thomas Hofmann

Mr. Thomas W. Hofmann is an Independent Director of West Pharmaceutical Services, Inc. Mr. Hofmann retired from Sunoco, Inc.—an oil refining and marketing company—in 2008, where he was Senior Vice President and CFO from January 2002 to December 2008. Mr. Hofmann served Sunoco in various other senior management roles since he joined in 1977.

Paula Johnson

Dr. Paula A. Johnson, M.D., MPH., is an Independent Director of West Pharmaceutical Services, Inc. Dr. Johnson has been President of Wellesley College since July 2016. Before joining Wellesley, Dr. Johnson founded and served as the inaugural Executive Director of the Connors Center for Women’s Health and Gender Biology, as well as Chief of the Division of Women’s Health at Brigham and Women’s Hospital. A cardiologist, Dr. Johnson was the Grace A. Young Family Professor of Medicine in the Field of Women’s Health—an endowed professorship named in honor of her mother—at Harvard Medical School. She was also Professor of Epidemiology at the Harvard T.H. Chan School of Public Health.

Deborah Keller Tanner

Ms. Deborah L. Keller Tanner is an Independent Director of the West Pharmaceutical Services, Inc. She serves as a Principal at Black Frame Advisors, LLC, and recently retired as Chief Executive Officer of Covance Drug Development, a business segment of Laboratory Corporation of America Holdings. Prior to serving as CEO, Ms. Keller spent more than 28 years at Covance in a number of leadership roles, including Corporate Executive Vice President and Group President of Research and Development Laboratories, Corporate Senior Vice President and President of Discovery and Translational Services, and Vice President of Analytical Services in Europe. Prior to joining Covance, Ms. Keller began her career as an Analytical Chemist at Perrigo Company.

Myla Lai-Goldman

Dr. Myla P. Lai-Goldman, M.D., is an Independent Director of West Pharmaceutical Services, Inc. Dr. Lai-Goldman has been Chief Executive Officer and President of GeneCentric Therapeutics, Inc.—a precision medicine company—since June 2011 and serves as director for the company. She is also managing partner of Personalized Science, LLC, a clinical diagnostics consulting company that she founded in 2008. Previously, Dr. Lai-Goldman was Chief Executive Officer and Chief Scientific Officer of CancerGuide Diagnostics, Inc. Before joining CancerGuide Diagnostics, she held various roles—including Executive Vice President, Chief Medical Officer and Chief Scientific Officer—at Laboratory Corporation of America Holdings and its predecessor company, Roche Biomedical Laboratories. Additionally, Dr. Lai-Goldman has been a venture partner at Hatteras Venture Partners since August 2011.

Douglas Michels

Mr. Douglas A. Michels is an Independent Director of West Pharmaceutical Services, Inc. Mr. Michels served as President and Chief Executive Officer of OraSure Technologies, Inc. and a member of the OraSure Board of Directors from June 2004. In December 2017, he announced his intention to resign from these positions effective March 31, 2018. In February 2010, Mr. Michels was appointed to the Presidential Advisory Council on HIV/AIDS. He previously served on the Board of the National Blood Foundation, the Board of the National Committee for Quality Health Care and the Coalition to Protect America’s Health Care.

Paolo Pucci

Mr. Paolo Pucci serves as Independent Director of the West Pharmaceutical Services, Inc. Mr. Pucci is Chief Executive Officer of ArQule, Inc., a biopharmaceutical company engaged in the research and development of targeted therapeutics. Prior to joining ArQule in 2008, Mr. Pucci worked at Bayer A.G., where he served in a number of leadership capacities including Senior Vice President of the Global Specialty Medicine Business Unit and was a member of the Bayer Pharmaceuticals Global Management Committee.

John Weiland

Mr. John H. Weiland is an Independent Director of West Pharmaceutical Services, Inc. Mr. Weiland served as President and Chief Operating Officer of C. R. Bard, Inc. — a medical-device company — from August 2003 to December 2017, when Bard was acquired by Becton, Dickinson and Company. In connection with that acquisition, Mr. Weiland retired. At Bard, he served as Group President from April 1997 to August 2003 and Group Vice President from March 1996 to April 1997. Mr. Weiland was elected to the Bard Board of Directors in April 2005 and became Vice Chairman of the Board in 2016. He received the prestigious Horatio Alger Award in 2012 and serves as a director of the Horatio Alger Association.